GO:1905522 negative regulation of macrophage migration: Signaling Checkpoints, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905522 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of macrophage migration.
• Macrophage migration inhibitory factor (MIF) is the founding soluble mediator of this process, and its structural and biological features were defined decades ago.
• Negative regulation of macrophage migration is not a single pathway; it integrates cytokine signaling, transcriptional reprogramming, and vesicle-mediated communication.
• Key molecular brakes include MCPIP1, NF-kB activator 1 (NKAP1/NFKB1), Wip1 (PPM1D), IRF7, and extracellular vesicle-delivered miR-146a-5p/miR-146b-5p.
• Dysregulation of this process contributes to mucosal inflammation, colorectal cancer progression, glioblastoma infiltration, pancreatic cancer, and recurrent spontaneous abortion.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to establish causality for candidate regulators of macrophage migration.
Description
Macrophages are motile innate immune cells that must reach peripheral tissues to perform surveillance, host defense, and tissue remodeling. The frequency, rate, and extent of their migration are tightly controlled, and the Gene Ontology term GO:1905522 (negative regulation of macrophage migration) captures every process that stops, prevents, or reduces this movement. The term is rooted in the discovery of macrophage migration inhibitory factor (MIF), a cytokine whose biological and structural features were characterized as a regulator of immune responses. Since then, the concept has expanded from a single secreted factor to a network of intracellular checkpoints, transcriptional programs, and extracellular vesicles that collectively restrain macrophage motility. For researchers, GO:1905522 is a useful annotation because it separates the act of migration from the regulation of that act. A gene product annotated to this term may act by altering cytoskeletal dynamics, by changing the transcriptional state of the macrophage, or by delivering inhibitory microRNAs to recipient cells. This distinction matters when interpreting single-cell and spatial transcriptomics data, where macrophage states are inferred from gene expression rather than direct motility assays. Understanding negative regulation of macrophage migration also has translational value. Excessive or misdirected macrophage infiltration drives glioblastoma progression and colorectal cancer immunosuppression, whereas insufficient restraint of trophoblast-directed macrophage signals contributes to recurrent spontaneous abortion. The sections below summarize the definition, the molecular players, the disease links, and the experimental methods used to study GO:1905522.
negative regulation of macrophage migration At A Glance
| GO ID | GO:1905522 |
|---|---|
| GO term | negative regulation of macrophage migration |
| Ontology | biological_process |
| Synonym | down regulation of macrophage migration; down-regulation of macrophage migration; downregulation of macrophage migration; inhibition of macrophage migration |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of macrophage migration |
| Founding mediator | Macrophage migration inhibitory factor (MIF) |
| Representative regulators | MCPIP1, NKAP1/NFKB1, Wip1 (PPM1D), IRF7, miR-146a-5p, miR-146b-5p |
| Associated processes | Mucosal inflammation, tumor immunosuppression, trophoblast invasion, osteoclastogenesis |
What Is GO:1905522?
According to the QuickGO definition, GO:1905522 is any process that stops, prevents, or reduces the frequency, rate, or extent of macrophage migration. In practice, this means a regulator can act by slowing the speed of individual macrophages, by reducing the proportion of macrophages that initiate movement, or by preventing macrophages from completing a migration program. The term is a biological process and is not restricted to a single molecular mechanism; it includes cytokine-mediated inhibition, transcriptional repression of pro-migratory genes, and vesicle-mediated delivery of inhibitory cargo.
Why Is negative regulation of macrophage migration Important in Cell Biology?
Negative regulation of macrophage migration is important because macrophage positioning determines whether an immune response resolves or becomes chronic. When this brake fails, macrophages accumulate in tissues and drive inflammatory pathology, tumor progression, and aberrant tissue remodeling. When the brake is excessive, protective macrophage functions such as pathogen clearance and normal trophoblast support can be impaired. The term therefore sits at the intersection of immunology, cancer biology, and reproductive biology, and it is a frequent annotation in single-cell studies that classify macrophage states.
• Controls the resolution phase of mucosal inflammation by limiting monocyte-to-macrophage maturation and tissue accumulation.
• Restrains glioblastoma-associated macrophage infiltration, which is a therapeutic target in brain tumors.
• Modulates adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer through macrophage-intrinsic signaling.
• Provides the mechanistic basis for MIF biology, one of the oldest known cytokine activities.
• Shapes the pancreatic cancer microenvironment through IRF7-dependent M1 macrophage states and lipid metabolism.
• Regulates trophoblast migration and invasion via macrophage-derived extracellular vesicles in recurrent spontaneous abortion.
• Is modulated by Wip1-dependent signaling that also affects phagocytosis.
• Influences osteoclastogenic trajectories, linking macrophage lineage regulation to bone biology.
• Serves as an annotation hub for interpreting single-cell and spatial transcriptomics of macrophage states.
• Provides causal targets for CRISPR-based validation in inflammation and cancer models.
What Happens During negative regulation of macrophage migration?
Initiation by soluble inhibitory signals
In simple terms: A signal molecule tells the macrophage to slow down or stop moving.
The classical initiation step for GO:1905522 is the engagement of macrophage migration inhibitory factor (MIF) with its cellular targets, a process whose biological and structural features were defined as a regulator of immune responses. MIF is a secreted mediator that reduces the frequency and extent of macrophage migration, and its activity established the conceptual foundation for the entire GO term. Additional soluble and vesicle-associated signals can initiate the same outcome, including extracellular vesicles that deliver inhibitory microRNAs to recipient cells.
Transcriptional reprogramming of the macrophage
In simple terms: The cell changes which genes are switched on, making it less motile.
Negative regulation of macrophage migration frequently requires changes in gene expression. MCPIP1 restrains mucosal inflammation by orchestrating the intestinal monocyte-to-macrophage maturation via an ATF3-AP1S2 axis, which alters the maturation state and migratory behavior of these cells. Similarly, downregulation of NF-kB activator 1 in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression, demonstrating that transcriptional rewiring can change macrophage positioning within tumors. IRF7 in M1 macrophages has also been linked to lipid metabolism-related mechanisms that inhibit pancreatic cancer occurrence, indicating that transcriptional identity and migratory restraint are coupled.
Post-transcriptional and vesicle-mediated control
In simple terms: Small RNA cargo and signaling phosphatases fine-tune how far a macrophage can travel.
Extracellular vesicles derived from M1 macrophages deliver miR-146a-5p and miR-146b-5p to suppress trophoblast migration and invasion by targeting TRAF6 in recurrent spontaneous abortion, illustrating that macrophage-derived vesicles can impose migratory restraint on neighboring cells. Within macrophages themselves, Wip1-dependent modulation of macrophage migration and phagocytosis shows that phosphatase signaling can set the threshold for motility. These post-transcriptional and signaling layers allow rapid adjustment of migration without new transcription.
Integration with tissue-level programs
In simple terms: The stop signal is coordinated with the broader tissue environment.
Negative regulation of macrophage migration does not occur in isolation. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target, showing that the balance between pro- and anti-migratory signals determines the final macrophage distribution in tumors. Integrative single-cell RNA-seq and ATAC-seq has identified a transcriptional and epigenetic blueprint guiding osteoclastogenic trajectory, which places macrophage lineage decisions in a chromatin context that can also constrain migration. Together, these studies indicate that GO:1905522 is executed through layered signaling, transcriptional, and epigenetic checkpoints.
Key Genes Involved in GO:1905522 negative regulation of macrophage migration
The following genes and proteins have been experimentally linked to negative regulation of macrophage migration or to closely related macrophage motility checkpoints in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MIF | Founding secreted mediator of macrophage migration inhibition | Structural and biological template for the GO term |
| MCPIP1 (ZC3H12A) | Restrains mucosal inflammation via ATF3-AP1S2 axis in monocyte-to-macrophage maturation | Links maturation control to migratory restraint in intestine |
| NKAP1 / NFKB1 pathway | Downregulation activates STAT3 and promotes adenoma-adenocarcinoma transition | Connects macrophage signaling to colorectal cancer progression |
| STAT3 | Effector of NKAP1 downregulation in macrophages | Transcriptional node for immunosuppression and migration |
| IRF7 | M1 macrophage transcription factor regulating lipid metabolism in pancreatic cancer | Single-cell and spatial transcriptomics target |
| TRAF6 | Target of miR-146a-5p and miR-146b-5p in trophoblast suppression | Vesicle-mediated migration control node |
| miR-146a-5p | EV-delivered microRNA suppressing trophoblast migration | Non-coding regulator of migration restraint |
| miR-146b-5p | EV-delivered microRNA suppressing trophoblast migration | Non-coding regulator of migration restraint |
| PPM1D (Wip1) | Phosphatase modulating macrophage migration and phagocytosis | Signaling threshold regulator |
| SPP1 (Osteopontin) | Mediates glioblastoma-associated macrophage infiltration | Therapeutic target in brain tumors |
| ATF3 | Transcription factor in MCPIP1-AP1S2 axis | Mucosal inflammation regulator |
| AP1S2 | Component of MCPIP1-ATF3 axis in monocyte-to-macrophage maturation | Intestinal macrophage maturation marker |
| M1 macrophage EV cargo | Delivers miR-146a-5p and miR-146b-5p | Cell-free regulator of migration |
| Osteoclastogenic trajectory genes | Chromatin blueprint guiding lineage decisions | ATAC-seq and scRNA-seq discovery platform |
| MCPIP1-ATF3 axis | Coordinates intestinal monocyte maturation | Inflammation resolution model |
| NF-kB activator 1 | Macrophage-intrinsic regulator of STAT3 activation | Colorectal cancer immunosuppression model |
| IRF7-lipid metabolism axis | M1 macrophage anti-tumor mechanism | Pancreatic cancer microenvironment model |
| Wip1 signaling | Modulates migration and phagocytosis | Redox biology and innate immunity model |
How Is negative regulation of macrophage migration Regulated?
Negative regulation of macrophage migration is itself regulated at multiple levels. At the extracellular level, MIF and other secreted factors initiate inhibitory signaling. At the transcriptional level, MCPIP1 coordinates an ATF3-AP1S2 axis that controls monocyte-to-macrophage maturation and mucosal inflammation, while NKAP1 downregulation activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression. At the post-transcriptional level, extracellular vesicles deliver miR-146a-5p and miR-146b-5p to suppress migration-associated targets such as TRAF6. Phosphatase signaling through Wip1 further modulates the threshold for migration and phagocytosis. Finally, chromatin accessibility changes captured by ATAC-seq during osteoclastogenic trajectory formation indicate that epigenetic state is an additional layer of regulation.
negative regulation of macrophage migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MCPIP1 (ZC3H12A) | Mucosal inflammation | Intestinal organoid and macrophage co-culture |
| NKAP1 / STAT3 | Colorectal adenoma-adenocarcinoma transition | Apc-mutant mouse and macrophage-specific knockout |
| IRF7 | Pancreatic cancer | Orthotopic pancreatic tumor model with scRNA-seq |
| TRAF6 / miR-146a-5p | Recurrent spontaneous abortion | Trophoblast invasion assay with EV treatment |
| SPP1 (Osteopontin) | Glioblastoma | Intracranial glioma model with macrophage tracking |
Mucosal inflammation and intestinal disease
MCPIP1 restrains mucosal inflammation by orchestrating the intestinal monocyte-to-macrophage maturation via an ATF3-AP1S2 axis, directly linking negative regulation of macrophage migration to inflammatory bowel disease biology. When this brake is impaired, monocytes may mature and accumulate inappropriately in the mucosa, sustaining inflammation.
Colorectal and pancreatic cancer
Downregulation of NF-kB activator 1 in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer, showing that loss of a macrophage-intrinsic checkpoint accelerates tumor progression. In pancreatic cancer, single-cell sequencing combined with spatial transcriptomics revealed that IRF7 in M1 macrophages inhibits cancer occurrence by regulating lipid metabolism-related mechanisms. These studies position GO:1905522 as a tumor-suppressive process in gastrointestinal cancers.
Glioblastoma and brain tumors
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target, indicating that blocking pro-migratory signals or enhancing negative regulation could reduce tumor-associated macrophage burden. The same principle applies to other tumors where macrophage infiltration correlates with poor outcome.
Reproductive disorders
Extracellular vesicles derived from M1 macrophages deliver miR-146a-5p and miR-146b-5p to suppress trophoblast migration and invasion by targeting TRAF6 in recurrent spontaneous abortion. This demonstrates that macrophage-derived negative regulation of migration can affect non-macrophage cell types at the maternal-fetal interface, with clinical implications for pregnancy loss.
From negative regulation of macrophage migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce negative regulation of macrophage migration? | CRISPR knockout in primary macrophages or macrophage cell lines |
| Does a specific phosphorylation site control the migration brake? | Point-mutation knock-in of the phospho-dead or phospho-mimetic residue |
| Does a disease-associated variant alter migration restraint? | Knock-in of the patient variant followed by live imaging |
| Where and when is the regulator expressed in tissue? | Tagged knock-in with fluorescent reporter and spatial transcriptomics |
| Can forced expression restore the migration brake? | Overexpression of the wild-type or mutant regulator |
| Which downstream effectors mediate the brake? | CRISPR library screening combined with migration readouts |
How to Study the negative regulation of macrophage migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Frequency and rate of macrophage movement | Testing inhibitory cytokines or EVs |
| Live-cell imaging | Speed and directionality of individual macrophages | Validating Wip1-dependent motility changes |
| Single-cell RNA-seq | Macrophage states and candidate regulators | Tumor and mucosal tissue profiling |
| Spatial transcriptomics | In situ localization of macrophage subsets | Pancreatic cancer microenvironment |
| ATAC-seq | Chromatin accessibility during lineage decisions | Osteoclastogenic trajectory mapping |
| Small RNA sequencing of EVs | Inhibitory microRNA cargo | Recurrent spontaneous abortion models |
| CRISPR knockout screen | Genes required for migratory restraint | Discovery of new GO:1905522 regulators |
| Phospho-proteomics | Signaling changes downstream of Wip1 or STAT3 | Mechanistic dissection of the migration brake |
Live imaging and migration assays
Direct measurement of macrophage motility is the gold standard for GO:1905522. Transwell, scratch-wound, and microfluidic assays quantify the frequency and rate of migration, while live-cell imaging tracks individual cells. These approaches are essential to confirm that a candidate regulator changes migration rather than only changing gene expression.
Single-cell and spatial transcriptomics
Single-cell RNA-seq combined with spatial transcriptomics can resolve macrophage states in situ and identify regulators such as IRF7 that correlate with migratory restraint. Integrative scRNA-seq and ATAC-seq further reveals the transcriptional and epigenetic blueprint guiding lineage decisions, including osteoclastogenic trajectories. These methods are powerful for discovering new candidates annotated to GO:1905522.
Vesicle and non-coding RNA profiling
Extracellular vesicles can carry inhibitory microRNAs such as miR-146a-5p and miR-146b-5p that suppress migration of recipient cells. Profiling EV cargo by small RNA sequencing and testing EV-treated cells in migration assays links non-coding regulators to GO:1905522.
CRISPR perturbation and functional validation
CRISPR knockout, point mutation, knock-in, and overexpression allow causal testing of candidate genes. For example, macrophage-specific knockout of MCPIP1 or NKAP1 pathway components can reveal effects on maturation, migration, and disease progression. Pooled CRISPR screens with migration-based selection can nominate new negative regulators for follow-up.
How CRISPR Can Be Used to Study GO:1905522 negative regulation of macrophage migration
Knockout
CRISPR knockout of candidate genes such as MCPIP1 or NKAP1 pathway components in macrophages can test whether they are required for negative regulation of macrophage migration. Loss-of-function models are particularly useful when the hypothesis is that the gene acts as a brake, because knockout is expected to increase migration.
Point Mutation
Point mutation is used to dissect specific residues, such as phosphorylation sites in Wip1 or STAT3, that control the migration brake. By introducing phospho-dead or phospho-mimetic mutations, researchers can determine whether a single post-translational modification is sufficient to alter macrophage motility.
Knock-in
Knock-in of disease-associated variants or fluorescent tags allows tracking of the regulator in vivo and testing of patient-specific mutations. Tagged knock-in lines are especially valuable for spatial transcriptomics and live imaging studies of macrophage migration.
Overexpression
Overexpression of a wild-type or mutant regulator can test sufficiency: if forced expression reduces macrophage migration, the gene is a candidate negative regulator. This approach is often used for microRNA cargo or secreted factors such as MIF.
How EDITGENE Supports negative regulation of macrophage migration Research
Researchers studying negative regulation of macrophage migration-related genes often need to determine whether a candidate gene is causally involved in restraining motility or is merely correlated with a macrophage state. CRISPR-based perturbation, combined with migration assays and single-cell readouts, provides the most direct way to establish causality.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of macrophage migration research.
Frequently Asked Questions About negative regulation of macrophage migration
What is GO:1905522 negative regulation of macrophage migration?
GO:1905522 is a Gene Ontology biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of macrophage migration.
What genes are involved in negative regulation of macrophage migration?
Key genes include MIF, MCPIP1 (ZC3H12A), NKAP1/NFKB1, STAT3, IRF7, TRAF6, PPM1D (Wip1), and SPP1 (Osteopontin), as well as non-coding regulators such as miR-146a-5p and miR-146b-5p.
How is negative regulation of macrophage migration studied?
Common methods include Transwell and live-cell migration assays, single-cell RNA-seq, spatial transcriptomics, ATAC-seq, EV small RNA sequencing, and CRISPR perturbation screens.
Why is negative regulation of macrophage migration important in cancer?
It restrains tumor-associated macrophage infiltration and immunosuppression; loss of this brake is linked to glioblastoma, colorectal cancer, and pancreatic cancer progression.
What is the role of MIF in macrophage migration?
MIF is the founding secreted mediator of macrophage migration inhibition, and its biological and structural features were characterized as a regulator of immune responses.
How do extracellular vesicles regulate macrophage migration?
M1 macrophage-derived extracellular vesicles deliver miR-146a-5p and miR-146b-5p to suppress migration-associated targets such as TRAF6 in recurrent spontaneous abortion.
What is the connection between GO:1905522 and mucosal inflammation?
MCPIP1 restrains mucosal inflammation by orchestrating intestinal monocyte-to-macrophage maturation via an ATF3-AP1S2 axis, linking the migration brake to inflammatory bowel disease biology.
Can CRISPR be used to study negative regulation of macrophage migration?
Yes. CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate regulators in migration assays and disease models.
Which diseases are associated with defective negative regulation of macrophage migration?
Associated conditions include mucosal inflammation, colorectal cancer, glioblastoma, pancreatic cancer, and recurrent spontaneous abortion.
What is the role of Wip1 in macrophage migration?
Wip1 (PPM1D) modulates macrophage migration and phagocytosis, acting as a signaling threshold regulator.
Conclusion
GO:1905522 (negative regulation of macrophage migration) is a biologically_process term that captures the diverse mechanisms which restrain macrophage motility. From the founding discovery of MIF to modern single-cell and spatial studies of MCPIP1, NKAP1, IRF7, and vesicle-delivered microRNAs, the field has moved from a single cytokine to a layered network of transcriptional, post-transcriptional, and epigenetic checkpoints. Because this process is central to inflammation, cancer, and reproductive biology, it is a high-value target for CRISPR-based causal studies. Knockout, point-mutation, knock-in, and overexpression models, combined with migration assays and multi-omic readouts, provide the tools needed to move from annotation to mechanism and from mechanism to therapeutic hypothesis.
References
- 1. Lu H et al.. 2023. MCPIP1 restrains mucosal inflammation by orchestrating the intestinal monocyte to macrophage maturation via an ATF3-AP1S2 axis.. Gut 72(5):882-895 PMID: 37015751
- 2. Wei J et al.. 2019. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.. J Clin Invest 129(1):137-149 PMID: 30307407
- 3. Wang S et al.. 2023. NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer.. BMC Med 21(1):115 PMID: 36978108
- 4. Bernhagen J et al.. 1998. Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features.. J Mol Med (Berl) 76(3-4):151-61 PMID: 9535548
- 5. Zhan T et al.. 2024. Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism-related mechanisms.. Clin Transl Med 14(8):e1799 PMID: 39118300
- 6. Ding J et al.. 2021. Extracellular vesicles derived from M1 macrophages deliver miR-146a-5p and miR-146b-5p to suppress trophoblast migration and invasion by targeting TRAF6 in recurrent spontaneous abortion.. Theranostics 11(12):5813-5830 PMID: 33897883
- 7. Tang Y et al.. 2017. Wip1-dependent modulation of macrophage migration and phagocytosis.. Redox Biol 13:665-673 PMID: 28822916
- 8. Das A et al.. 2025. Integrative single-cell RNA-seq and ATAC-seq identifies transcriptional and epigenetic blueprint guiding osteoclastogenic trajectory.. J Bone Miner Res 40(10):1127-1143 PMID: 40577680
